Superworth

Elutia EPS ELUT

Diluted earnings per share by quarter and over the last twelve months, from 2019.

Last 12 months, to Jun 30, 2026
$0.68
Latest quarter, Q2 FY26
−$0.17
Fiscal year 2025
$0.55

Elutia's earnings per share was $0.68 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.17.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025$0.55n/a
FY2024−$2.47n/a
FY2023−$2.11n/a
FY2022−$2.40n/a
FY2021−$2.36n/a
FY2019n/an/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.17n/a$0.68
Q1 FY26−$0.17n/a$0.59
Q4 FY25$1.21n/a$0.55
Q3 FY25−$0.19n/a−$0.92
Q2 FY25−$0.26n/a−$1.06
Q1 FY25−$0.21n/a−$1.93
Q4 FY24−$0.26n/a−$2.47
Q3 FY24−$0.33n/a−$2.61
Q2 FY24−$1.13n/a−$2.85
Q1 FY24−$0.75n/a−$2.37
Q4 FY23−$0.40n/a−$2.11
Q3 FY23−$0.57n/a−$2.09

Against its peers

Companies in Healthcare nearest Elutia's size, closest first, today.

CompanyEPS, 12 monthsGrowth
ELUTElutia$0.68
NEPHNephros$0.16+33% a year
ATNMActinium Pharmaceuticals$0.36
APTAlpha Pro Tech$0.41+24% a year
SPROSpero Therapeutics$0.11
LFVNLifevantage$0.40−46% a year
ICCCImmucell$0.08−58% a year
KEQUKewaunee Scientific$2.76−33% a year
PDEXPro DEX$4.11+52% a year
PLXProtalix BioTherapeutics$0.23+283% a year
NATRNatures Sunshine Products$1.01+36% a year
Peer median$0.38

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Elutia

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.